Xintela

Xintela Dividend Coverage

Dividend Coverage Ratio of Xintela (XINT.ST) as of Oct 26, 2026.

Dividend Coverage

-

Last updated:

Dividend Coverage Ratio of Xintela is 2026 - . Dividend Coverage Ratio of Xintela was 2025 - . It decreases by % lower compared to the previous year.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Xintela Stock analysis

What does Xintela do? Xintela AB, based in Lund, Skåne, develops pharmaceutical products in the Health Care sector, specifically focusing on regenerative medicine for cartilage damage and osteoarthritis, as well as treatments for glioblastoma brain tumors. The company utilizes therapeutic antibodies and XINMARK, a marker technology using specific proteins to identify stem cells for cartilage development. Listed on 22 March 2016, Xintela operates within biotechnology, targeting innovative therapies in oncology and orthopedics. Xintela is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Xintela stock

On Eulerpool you can find the complete historical development of Dividend Coverage Ratio Xintela since 2006 – with annual values, charts, and detailed analysis.

The dividend coverage ratio measures how many times dividends can be covered by net income. Higher coverage suggests more sustainable dividend payments.

Dividend Coverage Ratio's is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Dividend Coverage Ratio's Xintela historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Dividend — Xintela

All Key Metrics — Xintela